SCHEMBL2803944

SCHEMBL2803944

CNc1ncc2c(n1)-c1ccccc1C1(CCN(Cc3ccc(C(F)(F)F)cc3)CC1)C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 10/20 0.41
DRD2 P14416 3/20 0.41
HTR2A P28223 3/20 0.41
HTR2C P28335 3/20 0.41
HTR2B P41595 3/20 0.41
OPRL1 P41146 3/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
ACHE P22303 2/20 0.37
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
BCHE P06276 1/20 0.37
BACE1 P56817 1/20 0.37
HCRTR2 O43614 1/20 0.37
CHKA P35790 1/20 0.36
MCHR2 Q969V1 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2805393 0.90 OPRL1 (0.42) SIGMAR1OPRL1GAAALDH1A1KDM4E
SCHEMBL2803730 0.90 SIGMAR1 (0.45) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL2805415 0.90 SIGMAR1 (0.46) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL2805196 0.89 SIGMAR1 (0.50) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL2802601 0.89 SIGMAR1 (0.47) SIGMAR1ALDH1A1KDM4ETP53CYP1A2
SCHEMBL2803126 0.86 SIGMAR1 (0.53) SIGMAR1DRD2HTR2AHTR2CHTR2B
SCHEMBL2804234 0.85 USP2 (0.40) SIGMAR1ALDH1A1TP53CYP1A2CYP3A4
SCHEMBL2804232 0.85 USP2 (0.40) SIGMAR1ALDH1A1TP53CYP1A2CYP3A4
SCHEMBL2804117 0.85 SIGMAR1 (0.41) SIGMAR1DRD2OPRL1POLBALDH1A1
SCHEMBL2805765 0.85 SIGMAR1 (0.42) SIGMAR1DRD2HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
EP-2379506-B1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE INC (US) 2015-09-02 EP disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-8357694-B2 Substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds ARQULE, INC. (US) 2013-01-22 US disclosed
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-09-23 US disclosed
WO-2010078421-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F] ISOQUINOLIN-2-AMINE COMPOUNDS ARQULE, INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100239525-A1 SUBSTITUTED 5,6-DIHYDRO-6-PHENYLBENZO[F]ISOQUINOLIN-2-AMINE COMPOUNDS NQO1, DPYD, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 SIGMAR1 2817/4885DRD2 829/4885HTR2A 429/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.